Evidence map›Paper›PMID 40751476›Full record

ArticleHaemophilia : the official journal of the World Federation of Hemophilia2025

Managing Haemophilic Arthropathy in People With Haemophilia in Japan: An Informal Consensus.

Kumiko Ono, Azusa Nagao, Yusuke Inagaki, Kagehiro Amano, Miwa Goto, Makoto Kaneda, Kenichiro Makino, Chiai Nagae, Akihiro Sawada, Rie Shirayama and 4 more

Abstract read
In one paragraph

Article in Haemophilia : the official journal of the World Federation of Hemophilia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Managing Haemophilic Arthropathy in People With Haemophilia in Japan: An Informal Consensus.Haemophilia : the official journal of the World Federation of Hemophilia · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kumiko OnoDivision of Therapeutic Development for Intractable Bone Diseases, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Azusa NagaoDepartment of Hematology and Oncology, Kansai Medical University Hospital, Osaka, Japan.ORCID https://orcid.org/0000-0002-1126-1498
Yusuke InagakiDepartment of Rehabilitation Medicine, Nara Medical University, Kashihara, Japan.
Kagehiro AmanoDepartment of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.
Miwa GotoRehabilitation Center, The University of Tokyo Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-5139-2046
Makoto KanedaDepartment of Paediatrics, Sapporo Tokushukai Hospital, Sapporo, Japan.
Kenichiro MakinoDepartment of Rehabilitation Medicine, Shin-Ouji Hospital, Kitakyushu, Japan.
Chiai NagaeDepartment of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan.
Akihiro SawadaDepartment of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Japan.
Rie ShirayamaDepartment of Pediatrics, University of Occupational and Environmental Health, Kitakyushu, Japan.ORCID https://orcid.org/0000-0002-1047-9428
Nobuaki SuzukiDepartment of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.ORCID https://orcid.org/0000-0003-2250-7964
Masahiro TakeyamaDivision of Hemophilia, Osaka National Hospital, Osaka, Japan.
Naoya YamasakiDivision of Transfusion Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Hideyuki TakedaniDepartment of Rehabilitation, NHO Tsuruga Medical Center, Tsuruga, Japan.

Funding

Chugai Pharmaceutical Co., Ltd.
6 · The paper itself

Abstract

introductionPeople with haemophilia who develop haemophilic arthropathy experience disabling physical effects, limiting functionality and quality of life (QOL). Although Clinical Practice Guidelines are available for haemophilia management, consensus on haemophilic arthropathy management is needed.

aimTo develop recommendations for haemophilic arthropathy management in people with haemophilia adapted to the Japanese medical setting.

methodsUsing an informal consensus method, a steering group of 14 clinical experts (orthopaedic, rehabilitation, paediatric, and haematology) in Japan developed 40 literature-based statements and 18 sub-statements related to haemophilic arthropathy management in people with haemophilia. A panel of 30 experts was surveyed by email about their level of agreement with each statement/sub-statement. Responses were tabulated to determine the level of agreement with each statement/sub-statement: strong consensus, consensus, non-consensus, and strong non-consensus.

resultsThe survey was completed by 27/30 respondents. Strong consensus/consensus was reached for 39 statements/sub-statements, non-consensus/strong non-consensus was reached for four (all related to pain assessment and management), and consensus/non-consensus was not reached for 15.

conclusionBased on insights from a wide range of clinical experts, recommendations for the management of haemophilic arthropathy in people with haemophilia in Japan were developed to aid in addressing the unique challenges faced by healthcare providers in the country. The survey findings indicate that diagnostic tools are needed to aid in haemophilic arthropathy diagnosis. Routine evaluations (physical function, joint ultrasound, QOL, and psychological), activities (physical therapy, rehabilitation, aerobic exercise, and sports), appropriate pain management, and proactive screening for osteoporosis are important when managing haemophilic arthropathy in people with haemophilia.

Indexed as

HemarthrosisHemophilia AJoint DiseasesConsensusDisease ManagementHumansJapanQuality of LifeSurveys and Questionnairesarthropathyhaemophiliaorthopaedicspaediatricrehabilitation

Identifiers

PMID40751476
PMCPMC12462597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.